These tools could potentially be beneficial in the treatment of neurological conditions involving the α7 nAChR, including neuroinflammation, neuropathic pain, schizophrenia, and AD (Magnussen 2025; Luo and Huang 2024). The gene discussed is CHRNA7; the disease is Alzheimer disease.